id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-N-0202-0012,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of August 1, 2001 meeting - Transcript",Other,TR-Transcript,2009-01-07T05:00:00Z,2009,1,2009-01-07T05:00:00Z,,2009-01-07T22:07:42Z,,0,0,09000064804e37bf
FDA-2001-N-0202-0011,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of July 31, 2001 meeting - Transcript",Other,TR-Transcript,2009-01-07T05:00:00Z,2009,1,2009-01-07T05:00:00Z,,2009-01-07T22:07:41Z,,0,0,09000064804e379c
FDA-2001-N-0202-0004,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of the July 28, 2004 Workshop (Pages 102-204) - Transcript",Other,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T14:34:33Z,,0,0,09000064804e37d2
FDA-2001-N-0202-0005,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of the July 28, 2004 Workshop (Pages 205-304) - Transcript",Other,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T15:18:40Z,,0,0,09000064804e37d7
FDA-2001-N-0202-0010,FDA,FDA-2001-N-0202,See FDA-2001-N-0202-0007,Supporting & Related Material,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T19:07:13Z,,0,0,09000064804e37ee
FDA-2001-N-0202-0003,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of the July 28, 2004 Workshop (Pages 1 - 101) - Transcript",Other,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T14:00:34Z,,0,0,09000064804e37cc
FDA-2001-N-0202-0007,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of the July 29, 2004 Workshop (Pages 1 - 100) - Transcript",Other,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T18:20:42Z,,0,0,09000064804e37e1
FDA-2001-N-0202-0009,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of the July 29, 2004 Workshop (Pages 201 - 273) - Transcript",Other,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T18:24:18Z,,0,0,09000064804e37ea
FDA-2001-N-0202-0008,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of the July 29, 2004 Workshop (Pages 101 - 200) - Transcript",Other,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T18:22:26Z,,0,0,09000064804e37e6
FDA-2001-N-0202-0006,FDA,FDA-2001-N-0202,"Workshop on Preclinical Testing for Endovascular Grafts Transcript of the July 28, 2004 Workshop (Pages 305-397) - Transcript",Other,TR-Transcript,2004-10-26T04:00:00Z,2004,10,,,2009-01-08T16:00:59Z,,0,0,09000064804e37dc
FDA-2001-N-0202-0002,FDA,FDA-2001-N-0202,Workshop on Preclinical Testing for Endovascular Grafts,Notice,NM-Notice of Meeting,2001-10-10T04:00:00Z,2001,10,,,2009-01-07T16:52:55Z,,0,0,09000064804e3787
FDA-2001-N-0202-0001,FDA,FDA-2001-N-0202,Workshop on Preclinical Testing for Endovascular Grafts,Notice,NM-Notice of Meeting,2001-10-10T04:00:00Z,2001,10,,,2009-01-07T16:51:36Z,01–16471,0,0,09000064804e373f